TechflierTechflierTechflier
  • Home
  • News
  • Features
  • Spotlight
  • About
    • Mission
    • Services
    • Contact
  • Newsletter
  • Shop
    • All Items
    • By Category
      • Bags
      • T-Shirts
    • Cart
Search
© 2025 Techflier. All Rights Reserved.
Reading: Three European biotech founders on moving cancer science to patients
Share
Font ResizerAa
TechflierTechflier
Font ResizerAa
  • Home
  • News
  • Features
  • Spotlight
  • About
  • Newsletter
  • Shop
Search
  • Home
  • News
  • Features
  • Spotlight
  • About
    • Mission
    • Services
    • Contact
  • Newsletter
  • Shop
    • All Items
    • By Category
    • Cart
Have an existing account? Sign In
Follow US
© 2025 Techflier. All Rights Reserved.
Videos

Three European biotech founders on moving cancer science to patients

Three French deeptech founders compare notes on taking cancer therapies from the lab into patients.

Techflier Staff
Last updated: October 23, 2026 12:19 am
Techflier
Share
SHARE

A Women TechEU roundtable brings together the founders of Alga Biologics, Allogenica and InFocus Therapeutics, each attacking cancer from a different angle: microalgae-based antibody manufacturing, off-the-shelf T-cell therapies and AI-designed small molecules aimed at RNA. The conversation stays on what the work actually takes, from the science to the years between a result and a treatment.

A German publisher takes control of legal AI scale-up Noxtua
German biotech starts Europe’s biggest bacterial cellulose plant
Secondary share sale pushes Revolut past $115B valuation mark
12 Tech Startups from Kyiv You Need To Know About in 2025
a16z weighs which personal AI assistants are worth paying for
TAGGED:biotechcancer researchdeeptechEuropeFoundersWomen TechEU
SOURCES:EU-Startups
Share This Article
Facebook Copy Link Print
Previous Article PreScalar gives factory lines a way to update device firmware in place PreScalar gives factory lines a way to update device firmware in place
Next Article Lemkin and O'Driscoll weigh a venture market chasing trillion-dollar outcomes Lemkin and O’Driscoll weigh a venture market chasing trillion-dollar outcomes

Get Some Gear

 

 

 

 

Quick Links

  • News
  • Features
  • Spotlight
  • Newsletter
  • Store

About Techflier

  • About Techflier
  • Services
  • Contact Us
  • Privacy
  • Legal

Indices

TechflierTechflier
Follow US
© 2026 Techflier. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?